Last reviewed · How we verify

NCT04297696

The Effects of Exercises on Gait in Hemophilic Individuals

Completed NA Last updated 13 November 2020
What this trial tests

NA trial testing Therapeutic exercises in Hemophilic Arthropathy in 19 participants. Completed in 2 June 2020.

Timeline
1 January 2020
Primary endpoint
1 June 2020
2 June 2020

Quick facts

Lead sponsorCukurova University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment19
Start date1 January 2020
Primary completion1 June 2020
Estimated completion2 June 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Cukurova University

Who can join

18 and older, male only, with Hemophilic Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Arthropathy characterized by synovitis, cartilage degeneration, subchondral and interosseous cysts occur due to hemorrhage in hemophilia. This situation causes to chronic pain, decreasing in range of motion, muscle strength, proprioception. Disorders in these parameters are the main causes of gait dysfunction. The aim of this study is to investigate the effects of therapeutic exercises on target joint functions and gait kinematics, and to determine possible complications related to exercise in hemophilic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Therapeutic exercises

Trials testing the same drug.

Other Cukurova University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04297696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing